Management of new-onset atrial fibrillation in the emergency department: Is there any predictive factor for early successful cardioversion?

European Journal of Emergency Medicine

Volumn 12, Issue 2, 2005, Pages 52-56

  Zahir, Soheil ^a   Lheureux, Philippe ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Atrial fibrillation; Cardioversion; Emergency department

Indexed keywords

AGE; ARTICLE; BELGIUM; CARDIOVERSION; DYSPNEA; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; STATISTICS; TREATMENT OUTCOME;

AGE FACTORS; ATRIAL FIBRILLATION; BELGIUM; DYSPNEA; ELECTRIC COUNTERSHOCK; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 21744455013     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/00063110-200504000-00003     Document Type: Article

References (22)

1. Prystowsky E. Atrial fibrillation. In: Topol EJ (editor): Textbook of cardiovascular medicine. Philadelphia: Lippincott-Raven; 1998, pp. 1827-1861.
2. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23: 1535-1540.
3. Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996; 78: 1433-1436.
4. Cabin HS, Clubb KS, Hall C, Perlmutter RA, Feinstein AR. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 1990; 65: 1112-1116.
5. Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986; 17: 622-626.
6. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001; 22: 1852-1923.
7. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-473.
8. Ricard P, Levy S, Trigano J, Paganelli F, Daoud E, Man KC, et al. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997; 79: 815-816.
9. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968.
10. Franz MR, Karasik PL, Li C, Moubarak J, Chavez M. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997; 30: 1785-1792.
11. Daoud EG, Marcovitz P, Knight BP, Goyal R, Man KC, Strickberger SA, et al. Short-term effect of atrial fibrillation on atrial contractile function in humans. Circulation 1999; 99: 3024-3027.
12. Mulcahy B, Coates WC, Henneman PL, Lewis RJ. New-onset atrial fibrillation: when is admission medically justified? Acad Emerg Med 1996; 3: 114-119.
13. Michael JA, Stiell IG, Agarwal S, Mandavia DP. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med 1999; 33: 379-387.
14. Joseph AP, Ward MR. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med 2000; 36: 1-9.
15. Falk RH. Atrial fibrillation. N Engl J Med 2001; 344: 1067-1078.
16. Peters NS, Schilling RJ, Kanagaratnam P, Markides V. Atrial fibrillation: strategies to control, combat, and cure. Lancet 2002; 359: 593-603.
17. Koenig BO, Ross MA, Jackson RE. An emergency department observation unit protocol for acute-onset atrial fibrillation is feasible. Ann Emerg Med 2002; 39: 374-381.
18. Weigner MJ, Caulfield TA, Danias PG, Silverman DI, Manning WJ. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med 1997; 126: 615-620.
19. Levy S, Breithardt G, Campbell RW, Camm AJ, Daubert JC, Allessie M, et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1998; 19: 1294-1320.
20. Scott PA, Pancioli AM, Davis LA, Frederiksen SM, Eckman J. Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke 2002; 33: 2664-2669.
21. Harenberg J, Weuster B, Pfitzer M, Dempfle CE, Stehle G, Kubler W, Schlierf G. Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin. Semin Thromb Hemost 1993; 19(Suppl. 1): 116-121.
22. Murray RD, Deitcher SR, Shah A, Jasper SE, Bashir M, Grimm RA, Klein AL. Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation. J Am Soc Echocardiogr 2001; 14: 200-208.